All Stories

  1. Advancement in CAR T-Cell Therapy in Tumors
  2. Adverse Effects of CAR T-Cell Therapy and Management: Cytokine Release Syndrome and Neurotoxicity
  3. Clinical Success of CAR T Cells in Hematologic Cancers: Lessons from Leukemia and Lymphoma
  4. Combining CAR T Cells with Immunotherapies to Enhance Treatment Effectiveness
  5. Engineering CAR T Cells: Advances in Vector Design and Gene Editing
  6. From Bench to Bedside: Innovations and Challenges in CAR-T Cell Therapy Manufacturing and Regulation
  7. History and Evolution of CAR T-Cell Therapy
  8. Next-Generation CARs and Beyond: Synthetic Biology and Logic-Gates in Next-Generation CARs
  9. Optimizing CAR T-Cell Efficacy: Enhancing Proliferation, Persistence, and Memory
  10. Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
  11. Personalized CAR T-Cell Therapy: Tailoring to Patient-Specific Tumors
  12. Regulatory Landscape and Challenges in CAR-T Cell Therapy Development and Clinical Trials
  13. Biomarkers for targeted therapy and treatment decision making
  14. Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials
  15. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c Axis/NLRP3-NF-κB/Nrf-2-ARE signaling pathways to ameliorate the two-hit process in high-fat diet-induced hepatic steatosis
  16. Integrating CAR-T cells with other Immunotherapies for improved efficacy in cancer patients
  17. The Mediating Role of the Gut Microbiome in the Nutritional Prevention of Cancer
  18. Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a
  19. Application and Prospects of Nanotechnology for Water Treatment
  20. Current Status and Future Prospects of Nanotechnology in the Healthcare Industry
  21. Regulatory dynamics of Th17 lymphocytes in oral squamous cell carcinoma: immune modulation and emerging immunotherapies
  22. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights
  23. Molecular approaches of phytoremediation – a strategic regulator for pollution management
  24. Dissecting dietary hazards: cytogenotoxic impacts of monosodium glutamate, baking powder, and citric acid using Allium cepa assay
  25. Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings
  26. Natural Products and their Bioactive Compounds for the Prevention and Treatment of Diabetes Mellitus: A Systematic Review
  27. Prevalence of Cancer in India with Respect to Leukaemia and their Factorial Relations
  28. Nanoplatforms for precision imaging and targeted therapy in oncology
  29. Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response
  30. Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
  31. Detection Methods in HPV-Related Cancers
  32. CAR T-Cell Therapies against Viral Oncogenesis
  33. Cytomegalovirus (CMV)
  34. Difficulties in Promptly Diagnosing and Treating Neonatal Herpes Simplex Virus Infection
  35. Global Epidemiology of Oncogenic Viral Infections
  36. Hepatitis B Virus Infection
  37. Host–Viral Interactions during Oncogenic Infections
  38. Human T-Cell Leukemia Virus (HTLV)-Induced Carcinogenesis and Its Molecular Detection
  39. Immune Response Associated with Oncogenic Viral Diseases
  40. Laboratory Animal Model for Oncogenic Virus
  41. Malignant Transformation In Vitro by Oncogenic Viruses
  42. Molecular Cancer Drug Discovery
  43. Types of Viral Oncogenic Viral Diseases
  44. Vaccines
  45. Viral Oncology
  46. Evaluation of Bloodstream Infections Associated with Carbapenem-Resistant Enterobacteriaceae in Paediatric and Adult Patients
  47. Epigenetic analysis in cancer research
  48. Gene therapies for neurodegenerative disease: current knowledge and challenges
  49. Gene therapy under clinical trials for neurodegenerative diseases
  50. Introduction to cancer biology and current research trends
  51. Transgene delivery system: viral, nonviral, and other methods for central nervous system
  52. Emerging biomarkers for non-invasive cancer diagnosis and treatment
  53. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
  54. Method Optimization and Validation of Antibiotics Residues in Milk Sample Using LC-MS/MS
  55. The role of extracellular vesicles in the pathogenesis of gynecological cancer
  56. MicroRNAs in extracellular vesicles: A potential role in cancer progression
  57. Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
  58. Diagnosis and Treatment of Health Effects Caused by Airborne Contaminants
  59. Development of Personalized Medicine
  60. Nanobiotechnology in Personalized Oncology
  61. Phytoformulation with hydroxycitric acid and capsaicin protects against high-fat-diet-induced obesity cardiomyopathy by reducing cardiac lipid deposition and ameliorating inflammation and apoptosis in the heart
  62. Astroviruses: Overview and Emerging Disease
  63. Molecular Mechanisms of Human Papillomavirus-Induced Cervical Carcinogenesis
  64. Immunogenicity of cancer cells: An overview
  65. Risk Prediction and Diagnosis of Breast Cancer Using ML Algorithms
  66. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer
  67. An Updated Review on Influenza Viruses
  68. Avian Influenza: A Potential Threat to Human Health
  69. Crimean-Congo Haemorrhagic Fever Virus: A Complete Overview
  70. Novel Diagnostic Methods for Emerging Respiratory Viral Infection
  71. RAS: Circuitry and therapeutic targeting
  72. Effect of Allium Sativum on the Alcohol Induced Neuropathic Pain in Wistar Rats
  73. Cardiovascular Diseases and Nutraceuticals: Underlying Mechanism and Therapeutic Biomarkers
  74. Epigenetic Regulation of Breast Cancer
  75. Microbial indicators and methods for source tracking faecal contamination of groundwater
  76. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
  77. Expression profile of MUC1 protein in Pigeon allergens positive asthmatic
  78. Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
  79. Phytopharmaceuticals in Cancer Treatment
  80. Epigenetic Regulation of Breast Cancer
  81. Research Article Non-synonymous de novo gene mutations in Wilms’ Tumor: Identification and characterization of new variants of WT1 and WT2 loci in Indian Population
  82. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
  83. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line
  84. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women